https://www.thebodypro.com/category/adverse-events-comorbidities-hiv

Adverse Events, Comorbidities, and HIV

The Latest

empty shot
News

This Week in HIV Research: The Complexities of Alcohol and Substance Use

April 15, 2021: Alcohol and neurocognitive impairment; using hair analysis to measure substance use; integrase inhibitors' impact on verbal learning; hepatocellular carcinoma trends among PLWH.

By Barbara Jungwirth and Myles Helfand
David Alain Wohl recaps CROI 2021 research during a video interview
Conference Coverage

CROI 2021 Highlights: New HIV Research With Clinical Impact

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

By Myles Helfand
thumbnail CITY Jeremy Tjhung-25033
Features

Most Cancer Drug Trials Still Exclude People With HIV. That’s Both Unfounded and Dangerous.

Helping my longtime friend Jeremy find such trials alerted me to this ongoing problem—which will only be reversed if patients, doctors, and trial reviewers keep pushing back on Pharma.

By Tim Murphy
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

Sleep and Diet: Don’t Underestimate Their Importance for People Living With HIV

David Alain Wohl, M.D., on new findings from CROI 2021 that help us better understand the connections between sleep, diet, and quality of life among people living with HIV.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

Hypertension Control Emerges as Key Concern in Examination of HIV, Aging, and Cardiovascular Disease

David Alain Wohl, M.D., talks through new data presented at CROI 2021 that further our understanding of the interplay between HIV and comorbidities we often associate with aging, particularly those related to cardiovascular disease.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps COVID-19 research from CROI 2021
Conference Coverage

HIV & COVID-19: CROI 2021 Reveals New Research

David Alain Wohl, M.D., analyzes updated data regarding the intersection of HIV and COVID-19, with a particular focus on SARS-CoV-2 susceptibility and disease severity.

By David Alain Wohl, M.D.
liver
Interviews

Hepatitis D Infection Poses Greater Risks to People Living With HIV, Study Finds

New research suggests a high prevalence of hepatitis D, the most severe form of viral hepatitis, in PLWH in regions of Europe, and a particularly high risk for people who inject drugs.

By Terri Wilder, M.S.W.
COVID-19 mask ground
News

This Week in HIV Research: The Indirect Harms of the COVID-19 Pandemic

March 25, 2021: HIV disease progression spikes in a London hospital; neurocognitive impairment and frailty in PLWH; the smell of HIV-associated neurocognitive disorder; statin usage and physical function decline.

By Barbara Jungwirth and Myles Helfand
HPV
Conference Coverage

Anal Cancer Screening Must Include Women Living With HIV, Researchers Say

The incidence of anal cancer is rapidly growing in the United States, and may overtake cervical cancer within the next 10 years.

By Terri Wilder, M.S.W.
umbrella
News

This Week in HIV Research: Under One Roof

March 18, 2021: Improving viral suppression among PLWH experiencing homelessness; co-located PrEP services for trans women; subsidized health care and PrEP uptake; Heplisav-B hepatitis B vaccine efficacy in PLWH.

By Barbara Jungwirth and Myles Helfand